Colorectal cancer relapse predicted by immune cell infiltration

From Cleveland Clinic Lerner Research Institute: A research team led by Stephanie Schmit, PhD, MPH, Genomic Medicine Institute, has found that immune cell infiltration of colorectal cancer (CRC) tumors can predict disease relapse in patients who undergo surgery with curative intent. Published in OncoImmunology, the findings may help lead to more targeted post-operative surveillance strategies, which ultimately would improve prognosis for CRC patients at high risk for relapse. Dr. Schmit is a member of the Case Comprehensive Cancer Center's Cancer Prevention, Control & Population Research Program.

Continue reading